Tag: specimen validity testing industry analysis

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Specimen Validity Testing Market from 2024 to 2033?
The specimen validity testing market has experienced strong growth recently. It is expected to grow from $3.37 billion in 2023 to $3.68 billion in 2024, with a CAGR of 9.3%. Growth drivers include increasing drug adoption, enhanced drug screening, stringent regulations, higher alcohol consumption, and the integration of point-of-care testing.

The specimen validity testing market is expected to reach $5.27 billion by 2028 at a CAGR of 9.4%. This growth is attributed to rising demand for workplace drug testing, the adoption of oral fluid testing, and expanding applications in pain management. Key trends include AI integration and the development of portable testing devices.

Claim Your Free Sample of the Global Specimen Validity Testing Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15673&type=smp

What Key Factors Are Fueling the Growth of the Specimen Validity Testing Market?
The increase in drug abuse is expected to boost the specimen validity testing market. Drug abuse involves excessive use of substances for non-medical purposes, driven by factors like the opioid crisis and mental health issues. SVT methods assess impurities and compounds in drug tests. The Office for Health Improvement and Disparities noted an increase in adult interactions with drug and alcohol programs in the UK from April 2021 to March 2022. Additionally, the CDC reported a 15% rise in opioid overdose deaths in the US from 2020 to 2021. Therefore, increased drug abuse is driving this market.

What Are the Major Segments of the Specimen Validity Testing Market?
1) By Product And Service: Products; Service
2) By Testing Type: Laboratory Testing; Rapid Or Point-Of-Care Testing
3) By End-User: Drug Rehabilitation Centers; Drug Screening Laboratories; Pain Management Centers; Criminal Justice And Law Enforcement Agencies; Other End-Users

What New Trends Are Transforming the Specimen Validity Testing Market?
Companies in the specimen validity testing market are developing high-resolution urine drug testing profiles. Mayo Clinic Laboratories launched a data-driven UDT profile in July 2022, aiding addiction monitoring.

Order Now for Fast Delivery of Your Specimen Validity Testing Market Report!
https://www.thebusinessresearchcompany.com/report/specimen-validity-testing-global-market-report

Which Regions Are Driving Growth in the Specimen Validity Testing Market?
North America was the largest region in the specimen validity testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Specimen Validity Testing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the specimen validity testing market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Specimen Validity Testing Market Include

1. Specimen Validity Testing Market Executive Summary
2. Specimen Validity Testing Market Segments
3. Specimen Validity Testing Market Size And Template Market Growth Rate
4.  Key Specimen Validity Testing Market Trends
5. Major Specimen Validity Testing Market Drivers
……
25. Key Mergers And Acquisitions In The Specimen Validity Testing Market
26. Top Specimen Validity Testing Companies
27. Specimen Validity Testing Market Opportunities And Strategies
28. Specimen Validity Testing Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:
Hospital Acquired Infections Testing Kits Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Pharma Microbiology Testing Kits Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pharma-microbiology-testing-kits-global-market-report

Non-Invasive Prenatal Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

• Current Market Size: The specimen validity testing (SVT) market is projected to grow from $3.37 billion in 2023 to $3.68 billion in 2024, with a compound annual growth rate (CAGR) of 9.3%.
• Future Projections: By 2028, the market is expected to reach $5.27 billion, driven by a CAGR of 9.4%.

Growth Drivers

• Increased Drug Abuse: Rising drug abuse, including opioid addiction, is a significant factor driving market growth. SVT methods assess parameters such as pH, specific gravity, creatinine content, and temperature to detect drug abuse. For instance, opioid overdose deaths in the USA increased by 15% from 2020 to 2021.
• Workplace Drug Testing: Growing demand for workplace drug testing is boosting market expansion.
• Oral Fluid Testing: Increased adoption of oral fluid testing contributes to market growth.
• R&D Investments: Rising research and development operations are enhancing SVT technologies.
• Pain Management: Expanding applications in pain management are also driving market growth.

View More On The Specimen Validity Testing Market Report 2024 –
https://www.thebusinessresearchcompany.com/report/specimen-validity-testing-global-market-report

Key Trends

• Technological Advancements: Innovations in SVT technologies are improving accuracy and efficiency.
• AI Integration: Artificial intelligence is increasingly being integrated for more precise result interpretation.
• Product Innovations: New product developments, including portable testing devices, are emerging.
• Partnerships: Strategic partnerships among companies are expanding market reach and capabilities.

Key Developments

• High-Resolution Urine Drug Testing: In July 2022, Mayo Clinic Laboratories introduced a high-resolution urine drug testing profile (Mayo ID ADMPU) to aid physicians in managing substance addiction. This profile enhances sensitivity and specificity using advanced mass spectrometry and immunoassay techniques.
• Acquisition by Mesa Laboratories: In October 2021, Mesa Laboratories acquired Agena Bioscience for $300 million. This acquisition enhances Mesa’s capabilities in clinical genomics and sample validity testing.

Major Companies

• Key players in the SVT market include Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Medline Industries Inc., and Quest Diagnostics Incorporated, among others.

Market Segmentation

• By Product and Service: Products and services related to SVT.
• By Testing Type: Includes laboratory testing and rapid or point-of-care testing.
• By End-User: Drug rehabilitation centers, drug screening laboratories, pain management centers, and law enforcement agencies.

Regional Insights

• North America: Remains the largest market due to high adoption rates and advanced healthcare infrastructure.
• Asia-Pacific: Expected to be the fastest-growing region in the forecast period, driven by increasing healthcare investments and rising drug abuse concerns.

Conclusion

The specimen validity testing market is experiencing robust growth driven by increasing drug abuse, expanding applications in various sectors, and advancements in technology. With ongoing innovations and strategic expansions, the market is well-positioned for continued development, particularly in emerging regions like Asia-Pacific.

Request A Sample Of The Global Specimen Validity Testing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15673&type=smp